FDA Flags Evolus (EOLS) for Misleading Jeuveau Promotion on Instagram
gurufocus.com · 2026-10-02
On October 02, 2026, the U.S. Food and Drug Administration (FDA) contacted Evolus Inc (NASDAQ: EOLS) regarding concerns over a social media promotional post for
Read the full story at gurufocus.com →
Is EOLS undervalued? See TickrTrends' fair value analysis →